Showing results (1721-1730 of 1,814) with videos related to

Sort By:
Pageof 182
Breast Cancer Research : BCR|August 6, 2023
Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white womenLaurel A Habel, Stacey E Alexeeff, Ninah Achacoso, et al.
Cancer Discovery|September 16, 2015
RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 InhibitorsHaiying Cheng, Yiyu Zou, Jeffrey S Ross, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America RegionsArnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
Nature Medicine|June 27, 2025
A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnosticsN Furer, N Rappoport, O Milman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2009
WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activityJulie A Brennan, Radka Graf, Steven M Grauer, et al.
Nature Medicine|October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancerA Vaishnavi, M Capelletti, A T Le, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2014
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasmsRaajit Rampal, Jihae Ahn, Omar Abdel-Wahab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2016
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classesJ H Chung, E Sanford, A Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular TestingAlexa B Schrock, Garrett M Frampton, Dana Herndon, et al.
Nature Cancer|October 31, 2024
Global loss of promoter-enhancer connectivity and rebalancing of gene expression during early colorectal cancer carcinogenesisYizhou Zhu, Hayan Lee, Shannon White, et al.
Pageof 182